Osteoarthritis

There is no increased risk for COVID-19 infection or all-cause mortality among patients with osteoarthritis in primary care who receive NSAIDs, compared with other analgesics, according to data published in Arthritis & Rheumatology.

Physicians often weigh the uncertain efficacy of injectable drugs, and patients’ expectations, before offering intra-articular injections for osteoarthritis, according to findings published in Arthritis Care & Research.

Use of corticosteroid injections did not exacerbate radiographic progression of knee osteoarthritis or accelerate total knee replacement compared with hyaluronic acid, according to data presented at ACR Convergence 2020.

Treatment with warfarin is associated with a significantly greater risk for hip or knee replacement compared with direct oral anticoagulants, according to a speaker at ACR Convergence.

Interleukin-6 and neutrophil-to-lymphocyte ratio may be used as preoperative risk stratifying tools among patients undergoing total knee arthroplasty for osteoarthritis, according to results presented at the Virtual EFORT Congress.

At least 65% of rheumatologists at Veterans Affairs facilities view telemedicine as appropriate for established patients with gout, stable rheumatoid arthritis, osteoarthritis, stable spondyloarthritis and other diseases, researchers noted.

Research linking fluctuations in bone marrow lesions with pain fluctuations may suggest that targeting these lesions could successfully reduce osteoarthritis pain, according to a speaker at the 2020 Congress of Clinical Rheumatology-West.

Among patients with osteoarthritis, increased tanezumab doses are associated with a higher incidence of abnormal peripheral sensation compared with NSAIDs, according to a speaker at the 2020 American Neurological Association Annual Meeting.

High-intensity physical activity throughout early life can help prevent osteoporosis and maximize peak hip strength later, according to data published in JAMA Network Open.

Novel therapies are providing hope in osteoporosis, but questions surrounding optimal treatment regimens remain, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.